16 Jul 2018

Plan for phased re-introduction of hepatitis B vaccine for travellers

Public Heath England has agreed to accelerate the phased reintroduction of vaccine Plan for phased re-introduction of hepatitis B vaccine for travellers

Public Health England (PHE) advises that vaccine manufacturers GlaxoSmithKline (GSK) consider that the supplies of adult and paediatric Hepatitis B vaccine (Engerix B®) and renal vaccine (Fendrix®) are now sufficient to supply the UK market. Merck Sharp Dohme (MSD) UK expects current supplies of adult vaccine (HBvaxPRO™ 10mcgs) to last until October 2018 and then supplies will not resume until 2020 [1].

PHE has agreed to accelerate the phased reintroduction of vaccine outlined in the recovery plan, so that vaccine is now available for all priority groups 1 to 4 [1].

Combined hepatitis A/B vaccine continues to be available and is the preferred first line choice for travellers [2,3]. For those who have previously received hepatitis A vaccine, and require a primary course of hepatitis B for travel to countries where there is a NaTHNaC hepatitis B vaccine recommendation, single antigen hepatitis B vaccine, can be offered [1].

Advice for travellers

Advice on hepatitis B risk in specific countries is available on the TravelHealthPro Country Information pages.

Resources

Hepatitis B vaccine supply for travellers

PHE guidance on the supply of hepatitis B vaccine to the UK Read more

Updated information on country yellow fever certificate requirements

World Health Organization have published updates in International Travel and Health Read more

Worldwide rabies risk - reminder for travellers

NaTHNaC reminds all travellers of the global risk of rabies Read more

Zika virus transmission: Change to risk category, Rajasthan, India

The first cases of Zika virus are reported from Rajasthan, India Read more

Travelling for Diwali

Celebrating Diwali abroad? Careful preparation helps ensure a safe and enjoyable trip Read more
Back to Top

VIEW FULL INDEX